Medication-Assisted Recovery Journeys for Veterans

Written by The Recovery Village

& Medically Reviewed by Dr. Kevin Wandler, MD

Medically Reviewed

Up to Date

Editorial Policy

View our editorial policy

Key Takeaways

  • Medication-Assisted Recovery (MAR) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders, especially effective for opioid use disorders.
  • Veterans face a high prevalence of substance use disorders due to factors like combat exposure, PTSD, and chronic pain, with alcohol and prescription drug misuse being notably prevalent.
  • Medication-Assisted Treatment (MAT) for veterans includes medications like methadone, buprenorphine, and naltrexone, which help manage withdrawal symptoms and cravings.
  • Access to MAT is hindered by challenges such as stigma, geographical limitations, and institutional barriers, particularly for rural veterans.
  • Success stories of veterans in MAT highlight the treatment's effectiveness in improving mental health, relationships, and overall well-being.
  • Policy recommendations and budget proposals aim to enhance access to MAT for veterans, including investments to end veteran homelessness and prevent suicide.
  • Enhancing MAT effectiveness for veterans involves adopting patient-centered care strategies, integrated care models, and addressing social determinants of health.

Exploring Medication-Assisted Recovery for Substance Use Disorders

Medication-Assisted Recovery (MAR) is an integrated approach to treating substance use disorders that combines the use of FDA-approved medications with counseling and behavioral therapies. It represents a significant shift from the traditional abstinence-only models, offering a more comprehensive treatment plan that can improve patient outcomes and support long-term recovery. MAR is particularly effective in treating opioid use disorders (OUDs) and is considered a public health tool for managing addiction and preventing related complications, such as HIV/AIDS among injecting drug users.

There are three main types of medications used in MAR: buprenorphine, methadone, and naltrexone. These medications work by reducing cravings and withdrawal symptoms, blocking the effects of opioids, or a combination of both. The inclusion of counseling and behavioral therapies is crucial, as it addresses the psychological aspects of addiction, helping patients to develop coping strategies, improve emotional regulation, and address any underlying mental health conditions.

The concept of MAR aligns with the 'multiple pathways' approach to recovery, acknowledging that there are various ways to achieve and sustain recovery. This model bridges the gap between abstinence-based and medication-assisted philosophies, offering a more inclusive and potentially more effective approach to treatment. The National Alliance for Recovery Residences (NARR) recognizes the importance of recovery homes in providing different levels of support, from peer-operated to professionally-supported environments, which can complement MAR strategies.

Despite its effectiveness, MAR faces challenges such as the relapsing nature of OUD, the presence of comorbidities, and limited access to care in socioeconomically disadvantaged settings. However, by embracing a whole-patient approach and addressing both the medical and psychological needs, MAR represents a progressive step in the treatment of substance use disorders.

Prevalence and Impact of Substance Use Disorders in Veterans

Substance use disorders (SUDs) represent a significant health concern among military veterans, often stemming from the unique challenges and experiences faced during service. Research indicates a troubling prevalence of SUDs in this population, with factors such as combat exposure, mental health disorders like PTSD, and chronic pain being closely linked to substance misuse and addiction. Veterans with SUDs frequently have co-occurring mental health conditions, which complicates their treatment and recovery journey.

Alcohol misuse is notably prevalent among veterans, with higher rates of binge and heavy drinking compared to the general population. This is exacerbated by high levels of combat exposure, which increase the risk of problematic alcohol use. Prescription drug misuse, particularly opioids, is also rising among veterans, driven by prescriptions for pain management. The opioid crisis has significantly affected veterans, with overdose mortality rates climbing by 53% from 2010 to 2019. Cannabis use disorders have similarly seen a notable increase. The intersection of these substance use issues with mental health concerns, such as depression, anxiety, and PTSD, highlights the need for integrated treatment approaches.

Challenges in addressing SUDs among veterans include stigma, access to care, and adherence to treatment. Initiatives to improve outcomes often involve integrating SUD treatment with primary care and mental health services, as well as offering specialized programs for groups like female veterans. It is critical to incorporate the perspectives of veterans with lived experience into the design and implementation of treatment and prevention strategies, ensuring that these interventions are veteran-centered and address the unique needs of this population.

Prevalent Substance Use Challenges Among Veterans

Veterans often face unique challenges that can lead to substance use disorders (SUDs). Among the most commonly abused substances are alcohol, prescription pain medications, and illicit drugs. Alcohol use disorders are particularly prevalent due to alcohol's availability and its social acceptance as a coping mechanism for stress and trauma. Prescription opioids are another major concern, as they are frequently prescribed for pain management and can lead to dependence and addiction.

Beyond the substances themselves, veterans may struggle with co-occurring disorders such as post-traumatic stress disorder (PTSD) and depression, which can complicate recovery efforts. The stress of transitioning from military to civilian life, along with the potential for chronic pain from service-related injuries, further exacerbates the risk of substance abuse.

Addressing these challenges requires a multifaceted approach that includes improving access to mental health services, reducing the stigma associated with seeking help, and providing specialized programs that address the unique experiences of veterans. It is also critical to monitor prescription practices to prevent over-prescription and to offer alternative pain management strategies that reduce the risk of addiction.

Implementing Medication-Assisted Treatment for Veterans

Medication-Assisted Treatment (MAT) is a critical component in the treatment of substance use disorders (SUDs) among veterans. MAT combines FDA-approved medications with counseling and behavioral therapies to effectively treat opioid use disorders (OUD) and support long-term recovery. For veterans, MAT can be a lifeline, offering improved recovery outcomes and a better quality of life.

The types of medications commonly used in MAT for veterans include methadone, buprenorphine, and naltrexone. Methadone and buprenorphine help reduce opioid cravings and withdrawal symptoms, while naltrexone blocks the euphoric effects of opioids. Recent regulatory changes, such as the ability to prescribe medication through telehealth and the provision of take-home doses, have significantly increased access to these life-saving treatments.

Additionally, MAT for alcohol use disorders may involve medications like acamprosate, disulfiram, and naltrexone, which are prescribed post-detox to manage cravings and maintain sobriety. The use of these medications is often administered in a regulated medical setting due to their potential for abuse. Veterans seeking MAT may access these services through the VA or private facilities covered by veterans' health insurance.

Despite the challenges, including stigma and access barriers, MAT's benefits for veterans are substantial. MAT can improve patient survival, increase retention in treatment, decrease illicit substance use, and enhance the ability to gain and maintain employment. For pregnant veterans with SUDs, MAT can also lead to better birth outcomes. Ensuring that veterans have access to comprehensive MAT services is crucial for addressing the unique needs of this population.

Overview of Medications in MAT for Opioid Use Disorder

Medication-Assisted Treatment (MAT) for opioid use disorder (OUD) combines FDA-approved medications with counseling and behavioral therapies to effectively treat addiction and sustain recovery. The primary medications used in MAT include:

  • Methadone : A long-acting synthetic opioid agonist that suppresses withdrawal symptoms and cravings, methadone is administered in a controlled environment, such as an opioid treatment program.
  • Buprenorphine : Offered as a daily dissolving tablet or film, a monthly injection, or a six-month implant, buprenorphine prevents cravings and withdrawal symptoms and reduces the risk of overdose. It can be prescribed in various healthcare settings, including primary care.
  • Naltrexone : Known as a full opioid antagonist, naltrexone blocks the effects of opioids and is favored for its ease of use and minimal side effects. It is available as an oral tablet or a monthly injection.
  • Naloxone : A life-saving medication that rapidly reverses an opioid overdose. Naloxone can be administered via intranasal spray or injection.

These medications are integral to MAT and are backed by evidence showing they increase treatment adherence, reduce illicit opioid use, and decrease the risk of infectious diseases. Despite their effectiveness, access to MAT is limited by factors such as inadequate funding and a shortage of qualified providers. It is crucial to ensure that individuals seeking treatment for OUD are offered access to all available MAT options, tailored to their specific needs.

For more detailed information on the effectiveness and safety of MAT medications, visit the FDA's resource on MAT.

Advantages of Medication-Assisted Treatment for Veterans

Medication-Assisted Treatment (MAT) offers a multifaceted approach to substance use disorder recovery for veterans, integrating medications with counseling and behavioral therapies. MAT's benefits for veterans are substantial, providing improved recovery outcomes and enhancing their quality of life. By managing withdrawal symptoms and cravings through FDA-approved medications such as buprenorphine and methadone for opioid use disorders, and acamprosate, disulfiram, and naltrexone for alcohol use disorders, MAT helps stabilize body processes disrupted by substance misuse. This stabilization is crucial for veterans, who often face complex challenges due to their unique experiences and service-related stressors.

Additionally, MAT can be accessed through the VA or private facilities covered by veterans' health insurance, ensuring that those who served have access to comprehensive treatment programs. The combination of medication management and therapy sessions in MAT is designed to address the holistic needs of the individual, contributing to sustained recovery and preventing relapse. Importantly, MAT is administered in regulated medical environments to mitigate the potential for abuse of the treatment medications themselves.

With the VA's continued efforts to update policies and expand benefits, including a 3.2% increase in disability compensation rates and the Equity Action Plan, veterans receiving MAT are supported not only in their recovery journey but also in their overall well-being. Such initiatives demonstrate a commitment to improving the lives of veterans by ensuring they receive the comprehensive care and benefits they have earned.

Implementation Challenges of Medication-Assisted Treatment for Veterans

The implementation of Medication-Assisted Treatment (MAT) for veterans faces significant challenges, despite legislative efforts to improve access to care. The Veterans Choice and VA MISSION Acts aimed to provide veterans with more flexibility in accessing care outside of Veterans Health Administration (VHA) facilities. However, the expansion of community care, which accounted for 44% of VA's health care services in 2022, raises critical questions regarding the cost-effectiveness and quality of care compared to VHA-delivered services. Higher costs for community care could compel the VA to consider cost controls, potentially limiting access to community care, increasing cost-sharing, or restricting VHA enrollment.

Furthermore, the VA's efforts to expand health care and benefits for toxic-exposed veterans, as part of the PACT Act, require substantial investment in infrastructure and non-recurring maintenance to improve facility conditions. The proposed budget for 2024 includes a historic $4.1 billion for construction and $5 billion for medical care funding, which is essential for the VA to address environmental hazard exposures among veterans.

Despite these investments, the VA still faces the primary challenge of providing timely health care to veterans. A government watchdog has identified that after more than a decade, timely access to health care remains the top issue for the Department of Veterans Affairs. This indicates that while legislative changes and budget increases are steps in the right direction, the VA must overcome systemic hurdles to ensure that veterans receive the timely and effective care they need, including MAT services.

Addressing the Stigma Surrounding Medication-Assisted Treatment in Veterans

The stigma associated with Medication-Assisted Treatment (MAT) presents a significant barrier to its adoption among veterans suffering from opioid use disorder (OUD). Despite MAT's proven effectiveness in reducing illicit opioid use, improving treatment retention, and enhancing quality of life, its uptake remains low, especially in rural areas. The prevailing stigma stems from a variety of misconceptions and a historical preference for abstinence-based treatment approaches. This stigma can manifest as negative attitudes and beliefs within the veteran community, discouraging many from seeking or continuing MAT.

Efforts to reduce stigma are crucial to increase MAT uptake. This includes educating patients, healthcare providers, and the broader community about the benefits of MAT and challenging the notion that individuals on MAT are not truly in recovery. The perceptions of MAT in rural Appalachia highlight the need for targeted interventions to address these attitudes. Furthermore, the American Psychiatric Association (APA) emphasizes the role of psychiatrists in combating the opioid crisis by prescribing buprenorphine and other MAT medications, which can help normalize MAT as a standard treatment for OUD.

Addressing veteran-centered barriers, such as mistrust in the VA healthcare system and concerns about privacy, is also essential. The VA mental healthcare services study suggests both the Department of Veterans Affairs (VA) and the Department of Defense (DoD) need to work collaboratively to rebuild veterans' trust. Reducing bias and stigma associated with MAT not only improves care but is also a step towards honoring the service and sacrifices of veterans by ensuring they have access to the most effective treatments available for substance use disorders.

Addressing Barriers to MAT Access for Veterans

Access to Medication-Assisted Treatment (MAT) for veterans faces multiple challenges, including geographical, financial, and institutional barriers. Geographical disparities, particularly for rural veterans, significantly impact the availability of mental healthcare services. A Government Accountability Office (GAO) study found that rural veterans have lower access to mental healthcare than their urban counterparts, which extends to MAT services. Financially, the VA's budget has increased, with a proposed $4.1 billion investment for construction to improve healthcare facilities and a $5 billion investment in medical care funding for maintenance, as per the 2024 fiscal year budget. This budget aims to expand healthcare and benefits for veterans, including those exposed to environmental hazards.

Institutional challenges include the need for policy adaptations to meet growing demands for long-term care. Workforce shortages and a lack of providers, particularly in rural areas, are significant hurdles, as noted by the GAO. Additionally, there are policy barriers for Medicaid enrollees to access MAT, with the GAO recommending that the Department of Health and Human Services ensure state compliance with federal requirements to cover MAT medications. Despite these obstacles, initiatives like the No Barriers USA program and the VA's commitment to community care indicate progress in addressing these barriers for veterans seeking MAT.

Personal Triumphs: Veterans' Recovery Journeys with Medication-Assisted Treatment

Medication-Assisted Treatment (MAT) has been a pivotal component in the recovery journeys of many veterans struggling with substance use disorders. These stories of triumph and perseverance highlight both the challenges faced and the successes achieved through MAT. Veterans often face unique obstacles during recovery, including managing PTSD triggers, overcoming chronic pain from service-related injuries, and adjusting to civilian life. MAT, when combined with counseling and peer support, has proven to be an effective strategy in addressing these multifaceted issues.

For example, success stories from platforms like Make the Connection and The Recovery Village show veterans finding strength and community through shared experiences and group support. These narratives often reveal a transformation that extends beyond sobriety, touching on improved mental health, restored relationships, and renewed purpose. The journey is rarely easy, with many veterans grappling with societal stigma and the internal battle of feeling ready to seek help. Yet, the resilience displayed in these stories underscores the profound impact of MAT coupled with comprehensive support.

Programs like those offered by the American Red Cross and various VA initiatives provide recreational and therapeutic activities that contribute to the holistic recovery process. These accounts serve not only as a beacon of hope for other veterans but also as a testament to the effectiveness of MAT when integrated into a broader, personalized treatment plan.

Triumphs in Medication-Assisted Treatment: Veteran Success Stories

Medication-Assisted Treatment (MAT) has been a beacon of hope for many veterans struggling with substance use disorders. These success stories often go unnoticed but are vital in showcasing the effectiveness of MAT in the journey towards recovery. Veterans, who once served their country with honor, find themselves battling addiction, a formidable foe that requires a multifaceted approach to overcome. MAT combines medication with counseling and behavioral therapies, offering a whole-patient approach to the treatment of substance use disorders.

Success in MAT is not just about sobriety; it's about regaining control over one's life and finding purpose beyond military service. For example, veterans who have engaged in MAT report improvements in mental health, relationships, and overall well-being. They often speak of the crucial support received from healthcare providers, peer support groups, and family, which played a significant role in their recovery journey. These narratives are powerful reminders of resilience and the possibility of a new chapter post-service.

While specific veteran stories of MAT success are not detailed in the provided research, it is clear that the structure, discipline, and camaraderie learned in the military can be instrumental in a veteran's recovery process. The success of MAT in veterans' lives underscores the importance of accessible, veteran-centric healthcare services that address the unique challenges faced by those who have served. By highlighting these success stories, we not only honor the individuals' triumphs but also reinforce the message that recovery is attainable and sustainable with the right support and treatment.

Navigating MAT: Challenges for Veterans

Veterans embarking on medication-assisted treatment (MAT) journeys confront a unique set of challenges, often stemming from their military service and transition to civilian life. A primary concern is the prevalence of mental health issues, such as PTSD, which can complicate substance use disorders and MAT. The adjustment from active duty to civilian routines poses additional stressors that may exacerbate underlying conditions, creating barriers to successful treatment adherence.

Access to healthcare is another significant hurdle. Veterans may encounter long wait times for appointments, geographical limitations to care facilities, and inconsistencies in care quality, particularly when specialized treatments are required. These obstacles can deter veterans from seeking and continuing MAT. Moreover, the stigma surrounding MAT within the veteran community can lead to underutilization of these services, as many veterans may feel reluctant to seek help due to perceived judgment or misunderstanding from peers and society at large.

Despite these challenges, efforts are being made to improve the situation. The VA's Equity Action Plan aims to address disparities and ensure all veterans receive comprehensive care. Additionally, legislative updates, like the NDAA for Fiscal Year 2024, strive to support service-disabled veterans, potentially easing some burdens. To further assist, organizations like DAV provide guidance in navigating the complex world of benefits and healthcare, advocating for individualized support based on service background.

Understanding the unique experiences and healthcare needs of veterans is crucial for those providing MAT. This includes recognizing the risks associated with certain types of military service and the impact of military sexual trauma. As more data on veterans' healthcare utilization become available, continuous evaluation and adaptation of community care policies will be essential to ensure veterans have access to the health care they need, including effective MAT programs.

Enhancing Access and Effectiveness of Medication-Assisted Treatment for Veterans

Ensuring that veterans have access to medication-assisted treatment (MAT) is crucial for those grappling with substance use disorders (SUDs), particularly when these conditions co-occur with mental health disorders like PTSD or depression. A comprehensive approach that integrates evidence-based, patient-centered treatment can significantly improve outcomes for veterans. Research indicates that the conventional separation of SUD and mental health services may hinder recovery, suggesting a need for standardized, integrated care models.

Key strategies to enhance MAT access and effectiveness include:

  • Eliminating barriers such as the requirement for substance abstinence prior to receiving mental health care, which can discourage treatment for co-occurring disorders.
  • Expanding treatment availability and accessibility, especially in areas where veterans face geographical and financial barriers.
  • Increasing adoption of patient-centered, evidence-based treatments that address both SUDs and mental health issues concurrently.
  • Utilizing innovative technologies like telehealth services and immersive virtual reality experiences to extend reach and improve mental health outcomes.

By addressing these critical areas, healthcare providers and organizations can better support veterans in their recovery journeys, offering them a more holistic and effective path toward healing.

Policy Recommendations to Enhance Access to Medication-Assisted Treatment for Veterans

The fiscal year 2024 budget proposals and legislative actions reveal significant policy recommendations aimed at improving access to Medication-Assisted Treatment (MAT) for veterans. A key focus is on expanding healthcare services and enhancing funding to address the unique needs of veterans facing substance use disorders. The budget includes historic investments to end veteran homelessness and prevent veteran suicide, both of which are critical factors in substance abuse recovery.

Furthermore, the Toxic Exposures Fund and mandatory construction funding proposals indicate a commitment to improving facilities and resources that support MAT programs. The government's approach to realign and modernize VA healthcare includes a focus on early detection and treatment of conditions related to substance abuse, ensuring veterans receive the care they need. Additionally, the Fiscal Responsibility Act of 2023 provisions for VA medical care funding further support the expansion of essential health services for veterans, which would encompass MAT for those in need.

Enhancing the Effectiveness of Medication-Assisted Treatment for Veterans

Enhancing Medication-Assisted Treatment (MAT) effectiveness for veterans involves adopting patient-centered care (PCC) strategies, which prioritize the individual's preferences, needs, and values. According to research, evidence-based PCC interventions are crucial for health system leaders aiming to improve care quality. This requires a systematic approach, including the integration of care models that ensure continuity and support during transitions, as highlighted by systematic reviews.

Key elements of PCC include respect for patients' values, coordinated care, and emotional support, as discussed in the Israel Journal of Health Policy Research. Additionally, implementing care through the patient's perspective and focusing on leadership values and human resource policies that emphasize service and empathy are essential. Continuous measurement of the patient experience through surveys and qualitative methods is also vital for ongoing improvement.

Effective MAT also involves integrated care models that address both physical and behavioral health needs, as well as social determinants of health. According to the Center for Health Care Strategies, strategies like complex care management and trauma-informed care are instrumental in improving outcomes for patients with complex needs. To further improve MAT effectiveness, health systems should consider adopting integrated care quality frameworks that focus on the patient's entire care pathway, as suggested by BMC Health Services Research.

If you’re a military veteran seeking addiction treatment, The Recovery Village Cherry Hill at Cooper is here to help. We are a part of the VA Community Care Network, and we offer a trauma-informed program designed for veterans and first responders. Contact a Veteran Advocate today to learn more or to get started with treatment.


Get your life back

Recovery is possible. Begin your journey today

Call Us Now Admissions Check Insurance

What To Expect

When you call our team, you will speak to a Recovery Advocate who will answer any questions and perform a pre-assessment to determine your eligibility for treatment. If eligible, we will create a treatment plan tailored to your specific needs. If The Recovery Village is not the right fit for you or your loved one, we will help refer you to a facility that is. All calls are 100% free and confidential.

All calls are 100% free and confidential.